Top

Published in:

01-04-2013 | Original Paper

Predictors of Initial Uptake of Human Papillomavirus Vaccine Uptake Among Rural Appalachian Young Women

Authors: Baretta R. Casey, Richard A. Crosby, Robin C. Vanderpool, Mark Dignan, Wallace Bates

Published in: Journal of Prevention | Issue 1-2/2013

Abstract

Women in Appalachian Kentucky experience a high burden of cervical cancer and have low rates of human papillomavirus (HPV) vaccination. The purpose of this study was to identify normative influences predicting initial HPV vaccine uptake among a sample of young women in southeastern Kentucky. Women (N = 495), ages 18 through 26 years, were recruited from clinics and community colleges. After completing a questionnaire, women received a free voucher for HPV vaccination. Whether women redeemed the voucher for Dose 1 served as the primary outcome variable. Hierarchical logistic regression was used to estimate the influence of healthcare providers, friends, mothers, and fathers on vaccine uptake. One-quarter of the total sample (25.9 %) received Dose 1. Uptake was higher in the clinic sample (45.1 %) than in the college sample (6.9 %). On multivariate analysis, women indicating that their healthcare provider suggested the vaccine, that their friends would “definitely” want them to be vaccinated, and that their fathers would “definitely” want them to receive the vaccine all were 1.6 times more likely to receive Dose 1. Interaction effects occurred between recruitment site (clinic vs. community college) and all three of the normative influences retaining multivariate significance, indicating that the associations only applied to the clinic sample. HPV vaccine interventions may benefit from highlighting paternal endorsement, healthcare provider recommendation, and peer support.

Allen, J. D., Coronado, G. D., Williams, R. S., Glenn, B., Escoffery, C., Fernandez, M., et al. (2010). A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine, 28, 4027–4037.PubMedCrossRef

Allen, J. D., Mohllajee, A. P., Shelton, R. C., Othus, M. K., Fontenot, H. B., & Hanna, R. (2009). Stage of adoption of the human papillomavirus vaccine among college women. Preventive Medicine, 48, 420–425.PubMedCrossRef

Appalachian Regional Commission. (2010). County economic status in Appalachia, Fiscal Year 2011. Retrieved from http://www.arc.gov/research/MapsofAppalachia.asp?MAP_ID=54.

Behringer, B., & Friedell, G. H. (2006). Appalachia: Where place matters in health. Preventing Chronic Disease, 3, A113.PubMed

Bennett, K. K., Buchanan, J. A., & Adams, A. D. (2012). Social-cognitive predictors of intention to vaccinate against the human papillomavirus in college-age women. Journal of Social Psychology, 152, 480–492.PubMedCrossRef

Brewer, N. T., & Fazekas, K. I. (2007). Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Preventive Medicine, 45, 107–114.PubMedCrossRef

Bynum, S. A., Brandt, H. M., Sharpe, P. A., Williams, M. S., & Kerr, J. C. (2011). Working to close the gap: Identifying predictors of HPV vaccine uptake among young African American women. Journal of Health Care for the Poor and Underserved, 22, 549–561.PubMedCrossRef

Caskey, R., Lindau, S. T., & Alexander, G. C. (2009). Knowledge and early adoption of the HPV vaccine among girls and young women: Results of a national survey. Journal of Adolescent Health, 45, 453–462.PubMedCrossRef

Centers for Disease Control and Prevention. (2002). Cancer death rates—Appalachia, 1994–1998. Morbidity and Mortality Weekly Report, 51, 527–529.

Centers for Disease Control and Prevention. (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, 56(No. RR-2), 1–24.

Centers for Disease Control and Prevention. (2011). National and state vaccination coverage among adolescents aged 13 through 17 Years—United States, 2010. Morbidity and Mortality Weekly Report, 60, 1117–1123.

Centers for Disease Control and Prevention. (2012a). Adult vaccination coverage—United States, 2010. Morbidity and Mortality Weekly Report, 61, 66–72.

Centers for Disease Control and Prevention. (2012b). Genital HPV infection—fact sheet. Retrieved from http://www.cdc.gov/std/HPV/STDFact-HPV.htm.

Chao, C., Velicer, C., Slezak, J. M., & Jacobsen, S. J. (2010). Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. American Journal of Epidemiology, 171, 357–367.PubMedCrossRef

Cohen, E. L., & Head, K. J. (2013). HPV vaccine diffusion: Differences in risk communication among early-adopters and non-adopters. Journal of Health Communication.

Conroy, K., Rosenthal, S. L., Zimet, G. D., Jin, Y., Bernstein, D. I., Glynn, S., et al. (2009). Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. Journal of Women’s Health, 18, 1679–1686.PubMedCrossRef

Couto, R. A., Simpson, N. K., & Harris, G. (Eds.). (1994). Sowing seeds in the mountains: Community-based coalitions for cancer prevention and control. Bethesda, MD: Appalachia Leadership Initiative on Cancer, Cancer Control Sciences Program, Division of Cancer Prevention and Control, National Cancer Institute.

Crosby, R. A., Casey, B. R., Vanderpool, R., Collins, T., & Moore, G. R. (2011). Uptake of free HPV vaccination among young women: A comparison of rural versus urban rates. Journal of Rural Health, 27, 380–384.PubMedCrossRef

Crosby, R. A., & Miller, K. S. (2002). The pivotal role of the family on adolescent females’ sexual health. In G. M. Wingood & R. J. DiClemente (Eds.), Handbook of women’s sexual and reproductive health (pp. 113–128). New York, NY: Kluwer Academic/Plenum Publishers.CrossRef

Crosby, R. A., Salazar, L. F., & DiClemente, R. J. (2013). Value-expectancy theories. In R. J. DiClemente, L. F. Salazar, & R. A. Crosby (Eds.), Health behavior theory for public health: Principles, foundations, applications (pp. 65–82). Burlington, MA: Jones & Bartlett Learning.

Crosby, R., Schoenberg, N., Hopenhayn, C., Moore, G., & Melhan, W. (2007). Correlates of intent to be vaccinated against human papillomavirus: An exploratory study of college-aged women. Sexual Health, 4, 71–73.PubMedCrossRef

Dempsey, A., Cohn, L., Dalton, V., & Ruffin, M. (2011). Worsening disparities in HPV vaccine utilization among 19–26-year-old women. Vaccine, 29, 528–534.PubMedCrossRef

DiClemente, R. J., Wingood, G. M., Crosby, R., Cobb, B. K., Harrington, K., & Davies, S. L. (2001). Parent—adolescent communication and sexual risk behaviors among African American adolescent females. Journal of Pediatrics, 139, 407–412.PubMedCrossRef

Dishion, T. J., & Dodge, K. A. (2005). Peer contagion in interventions for children and adolescents: Moving towards an understanding of the ecology and dynamics of change. Journal of Abnormal Child Psychology, 33, 395–400.PubMedCrossRef

Dunne, E. F., Unger, E. R., Sternberg, M., McQuillan, G., Swan, D. C., Patel, S. S., et al. (2007). Prevalence of HPV infection among females in the United States. Journal of the American Medical Association, 297, 813–819.PubMedCrossRef

Gerend, M. A., & Shepherd, J. E. (2012). Predicting human papillomavirus vaccine uptake in young adult women: Comparing the health belief model and theory of planned behavior. Annals of Behavioral Medicine, 44, 1–10.CrossRef

Head, K. J., & Cohen, E. L. (2012). Young women’s perspectives on cervical cancer prevention in Appalachian Kentucky. Qualitative Health Research, 22, 476–487.PubMedCrossRef

Health Resources and Services Administration, U.S. Department of Health and Human Services. (2012). Health professional shortage areas (HPSAs) by State and County. Retrieved from http://hpsafind.hrsa.gov/HPSASearch.aspx.

Hopfer, S., & Clippard, J. R. (2011). College women’s HPV vaccine decision narratives. Qualitative Health Research, 21, 262–277.PubMedCrossRef

Huey, N. L., Clark, A. D., Kluhsman, B. C., & Lengerich, E. J. (2009). HPV vaccine attitudes and practices among primary care providers in Appalachian Pennsylvania. Preventing Chronic Disease, 6, A49.PubMed

Jain, N., Euler, G. L., Shefer, A., Lu, P., Yankey, D., & Markowitz, L. (2009). Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey—Adult 2007. Preventive Medicine, 48, 426–431.PubMedCrossRef

Juraskova, I., O’Brien, M., Mullan, B., Bari, R., Laidsaar-Powell, R., & McCaffery, K. (2012). HPV vaccination and the effect of information framing on intentions and behaviour: An application of the theory of planned behaviour and moral norm. International Journal of Behavioral Medicine, 19(4), 518–525.

Katz, M. L., Reiter, P. L., Heaner, S., Ruffin, M. T., Post, D. M., & Paskett, E. D. (2009a). Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine, 27, 3945–3952.PubMedCrossRef

Katz, M. L., Reiter, P. L., Kluhsman, B. C., Kennedy, S., Dwyer, S., Schoenberg, N., et al. (2009b). Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states. Vaccine, 27, 3195–3200.PubMedCrossRef

Kentucky Cancer Registry. (2012). Cervical cancer incidence, 2005–2009. Retrieved from http://www.kcr.uky.edu/.

Keating, K. M., Brewer, N. T., Gottlieb, S. L., Liddon, N., Ludema, C., & Smith, J. S. (2008). Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer. Journal of Adolescent Health, 43(4 Suppl), S61–S67.PubMedCrossRef

Kentucky Department for Public Health. (2008). Kentucky behavioral risk factor surveillance system 2008 annual report. Retrieved from http://chfs.ky.gov/NR/rdonlyres/73E49DF2-81D3-4E05-BDC3-DA348F4E7F1E/0/Kentucky2008BRFSSAnnualReport.pdf.

Kepka, D., Berkowitz, Z., Yabroff, K. R., Roland, K., & Saraiya, M. (2012). Human papillomavirus vaccine practices in the USA: Do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations? Sexually Transmitted Infections, 88, 433–435.PubMedCrossRef

Krawczyk, A. L., Perez, S., Lau, E., Holcroft, C. A., Amsel, R., Knäuper, B., et al. (2012). Human papillomavirus vaccination intentions and uptake in college women. Health Psychology, 31, 685–693.PubMedCrossRef

Krieger, J. L., Katz, M. L., Kam, J. A., & Roberto, A. (2012). Appalachian and non-Appalachian pediatricians’ encouragement of the human papillomavirus vaccine: Implications for health disparities. Women’s Health Issues, 22, e19–e26.PubMedCrossRef

Licht, A. S., Murphy, J. M., Hyland, A. J., Fix, B. V., Hawk, L. W., & Mahoney, M. C. (2010). Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception? Sexually Transmitted Infections, 86, 74–78.PubMedCrossRef

Marchand, E., Glenn, B. A., & Bastani, R. (2012). Low HPV vaccine coverage among female community college students. Journal of Community Health, 37(6), 1136–1144.PubMedCrossRef

Moore, G. R., Crosby, R. A., Young, A., & Charnigo, R. (2010). Low rates of free human papillomavirus vaccine uptake among young women. Sexual Health, 7, 287–290.PubMedCrossRef

Murray, C. J., Kulkarni, S. C., Michaud, C., Tomijima, N., Bulzacchelli, M. T., Iandiorio, T. J., et al. (2006). Eight Americas: Investigating mortality disparities across races, counties, and race-counties in the United States. PLoS Medicine, 3, e260.PubMedCrossRef

Padilla-Walker, L. M., & Bean, R. A. (2009). Negative and positive peer influence: Relations to positive and negative behaviors for African American, European American, and Hispanic adolescents. Journal of Adolescence, 32, 323–337.PubMedCrossRef

Roberts, M. E., Gerrard, M., Reimer, R., & Gibbons, F. X. (2010). Mother–daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics, 125, 982–989.PubMedCrossRef

Rodgers, J. L., Rowe, D. C., & Buster, M. (1998). Social contagion, adolescent sexual behavior, and pregnancy: A nonlinear dynamic EMOSA model. Developmental Psychology, 34, 1096–1113.PubMedCrossRef

Rosenthal, S. L., Weiss, T. W., Zimet, G. D., Ma, L., Good, M. B., & Vichnin, M. D. (2011). Predictors of HPV vaccine uptake among women aged 19–26: Importance of a physician’s recommendation. Vaccine, 29, 890–895.PubMedCrossRef

Teitelman, A. M., Stringer, M., Nguyen, G. T., Hanlon, A. L., Averbuch, T., & Stimpfel, A. W. (2011). Social cognitive and clinical factors associated with HPV vaccine initiation among urban, economically disadvantaged women. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 40, 691–701.PubMedCrossRef

U.S. Census Bureau, U.S. Department of Commerce. (2010). State and County QuickFacts: Kentucky. Retrieved from http://quickfacts.census.gov/qfd/states/21000.html.

Wingo, P. A., Tucker, T. C., Jamison, P. M., Martin, H., McLaughlin, C., Bayakly, R., et al. (2008). Cancer in Appalachia, 2001–2003. Cancer, 112, 181–192.PubMedCrossRef

Title: Predictors of Initial Uptake of Human Papillomavirus Vaccine Uptake Among Rural Appalachian Young Women
Authors: Baretta R. Casey
Richard A. Crosby
Robin C. Vanderpool
Mark Dignan
Wallace Bates
Publication date: 01-04-2013
Publisher: Springer US
Published in: Journal of Prevention / Issue 1-2/2013
Print ISSN: 2731-5533
Electronic ISSN: 2731-5541
DOI: https://doi.org/10.1007/s10935-013-0295-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Predictors of Initial Uptake of Human Papillomavirus Vaccine Uptake Among Rural Appalachian Young Women

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1-2/2013

Innovations in Primary Prevention: Emerging Research from CDC’s Prevention Research Centers

Understanding Problems with Condom Fit and Feel: An Important Opportunity for Improving Clinic-Based Safer Sex Programs

Community Health Partnerships for Chronic Disease Prevention Among Latinos: The San Diego Prevention Research Center

Correlates and Geographic Patterns of Knowledge That Physical Activity Decreases Cancer Risk

The Next Wave

It’s Your Game…Keep It Real: Can Innovative Public Health Prevention Research Thrive Within a Comparative Effectiveness Research Framework?